Xilio Therapeutics, Inc.

XLO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 5, 2026 4
4 Jan 5, 2026 4
8-K Jan 5, 2026 8-K
SCHEDULE 13G Dec 11, 2025
4 Dec 1, 2025 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
S-8 Nov 25, 2025 S-8
4 Nov 25, 2025 4
4 Nov 25, 2025 4
4 Nov 25, 2025 4
4 Nov 25, 2025 4
8-K Nov 25, 2025 8-K
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G Nov 14, 2025
10-Q Nov 13, 2025 10-Q
8-K Nov 13, 2025 8-K
8-K Nov 7, 2025 8-K
DEF 14A Oct 20, 2025 DEF 14A
PRE 14A Oct 10, 2025 PRE 14A
8-K Oct 3, 2025 8-K
8-K Sep 9, 2025 8-K
8-K Aug 28, 2025 8-K
SCHEDULE 13G/A Aug 14, 2025
SCHEDULE 13G/A Aug 14, 2025
10-Q Aug 14, 2025 10-Q
8-K Aug 14, 2025 8-K
← Newer Page 3 of 15 · 357 filings Older →